ProShares Ultra Health Care
19 hedge funds and large institutions have $14.2M invested in ProShares Ultra Health Care in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.
3,543% more call options, than puts
Call options by funds: $1.02M | Put options by funds: $28K
44% more capital invested
Capital invested by funds: $9.81M → $14.2M (+$4.34M)
14.22% more ownership
Funds ownership: 38.01% → 52.23% (+14%)
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
10% less funds holding
Funds holding: 21 → 19 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$2.19M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.2M |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.04M |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$64.3K |
| 5 |
TFA
Toth Financial Advisory
Leesburg,
Virginia
|
+$5.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
-$447K |
| 2 |
WA
Wealth Advisors
Rancho Santa Fe,
California
|
-$415K |
| 3 |
Envestnet Asset Management
Chicago,
Illinois
|
-$217K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$91.8K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$48.2K |
RXL Hedge Fund Activity: Q3 2020 in Review
19 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in ProShares Ultra Health Care (RXL) for Q3 2020, worth a combined $14.2M — up 44% from $9.81M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of RXL and 0 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was Citadel Advisors, adding an estimated $2.19M. The largest seller was Simplex Trading, exiting entirely with an estimated $447K sold.
- 19 institutional investors held ProShares Ultra Health Care (RXL) as of Q3 2020, down from 21 in Q2 2020.
- Funds reported $14.2M of ProShares Ultra Health Care stock for Q3 2020, up 44% quarter-over-quarter.
- 0 funds opened new ProShares Ultra Health Care positions in Q3 2020 and 2 closed out, a net change of -2 holders.
- The largest ProShares Ultra Health Care buyer in Q3 2020 was Citadel Advisors, an estimated $2.19M added.
- The largest ProShares Ultra Health Care seller in Q3 2020 was Simplex Trading, an estimated $447K sold.
Based on aggregated 13F filings for Q3 2020.